Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Gale

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Leukemia|March 16, 2002
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemiaS E Langabeer, R E Gale, R C Harvey, et al.
Leukemia|October 6, 2012
PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic responseC Shepherd, L Banerjee, C W Cheung, et al.
British Journal of Haematology|October 16, 1999
Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic valueC N Harrison, R E Gale, F Pezella, et al.
British Journal of Haematology|April 1, 1996
Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patternsR E Gale, C Bunch, D J Moir, et al.
British Journal of Haematology|June 10, 2000
Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patternsJ D Robertson, R E Gale, R F Wynn, et al.
British Journal of Haematology|March 1, 1997
Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working PartyS E Langabeer, H Walker, R E Gale, et al.
Histopathology|May 12, 2007
A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in boneB D Idowu, M Al-Adnani, P O'Donnell, et al.
Leukemia|July 4, 2008
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosisD Bowen, M J Groves, A K Burnett, et al.
British Journal of Haematology|February 1, 1977
Haemoglobin Radcliffe (alpha2beta299(Gi)Ala): a high oxygen-affinity variant causing familial polycythaemiaD J Weatherall, J B Clegg, S T Callender, et al.
Leukemia|June 21, 2013
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemiaC Allen, R K Hills, K Lamb, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Leukemia|March 16, 2002
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemiaS E Langabeer, R E Gale, R C Harvey, et al.
Leukemia|October 6, 2012
PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic responseC Shepherd, L Banerjee, C W Cheung, et al.
British Journal of Haematology|October 16, 1999
Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic valueC N Harrison, R E Gale, F Pezella, et al.
British Journal of Haematology|April 1, 1996
Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patternsR E Gale, C Bunch, D J Moir, et al.
British Journal of Haematology|June 10, 2000
Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patternsJ D Robertson, R E Gale, R F Wynn, et al.
British Journal of Haematology|March 1, 1997
Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working PartyS E Langabeer, H Walker, R E Gale, et al.
Histopathology|May 12, 2007
A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in boneB D Idowu, M Al-Adnani, P O'Donnell, et al.
Leukemia|July 4, 2008
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosisD Bowen, M J Groves, A K Burnett, et al.
British Journal of Haematology|February 1, 1977
Haemoglobin Radcliffe (alpha2beta299(Gi)Ala): a high oxygen-affinity variant causing familial polycythaemiaD J Weatherall, J B Clegg, S T Callender, et al.
Leukemia|June 21, 2013
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemiaC Allen, R K Hills, K Lamb, et al.
Pageof 6